Effect of Bamlanivimab vs Placebo on Incidence of COVID-19 among Residents and Staff of Skilled Nursing and Assisted Living Facilities: A Randomized Clinical Trial

Myron S. Cohen, Ajay Nirula, Mark J. Mulligan, Richard M. Novak, Mary Marovich, Catherine Yen, Alexander Stemer, Stockton M. Mayer, David Wohl, Blair Brengle, Brian T. Montague, Ian Frank, Russell J. McCulloh, Carl J. Fichtenbaum, Brad Lipson, Nashwa Gabra, Julio A. Ramirez, Christine Thai, Wairimu Chege, Margarita M. Gomez LorenzoNirupama Sista, Jennifer Farrior, Meredith E. Clement, Elizabeth R. Brown, Kenneth L. Custer, Jacob Van Naarden, Andrew C. Adams, Andrew E. Schade, Matan C. Dabora, Jack Knorr, Karen L. Price, Janelle Sabo, Jay L. Tuttle, Paul Klekotka, Lei Shen, Daniel M. Skovronsky

Research output: Contribution to journalArticlepeer-review

79 Scopus citations

Fingerprint

Dive into the research topics of 'Effect of Bamlanivimab vs Placebo on Incidence of COVID-19 among Residents and Staff of Skilled Nursing and Assisted Living Facilities: A Randomized Clinical Trial'. Together they form a unique fingerprint.

Medicine & Life Sciences